Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Davis, T. M.
Right arrow Articles by Batty, K. T
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The role of pharmaceutical care in diabetes management

Timothy Me Davis

School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, Australia, tdavis{at}cyllene.uwa.edu.au

Rhonda M Clifford

School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia, Nedlands, Australia

Wendy A Davis

School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, Australia

Kevin T Batty

School of Pharmacy, Curtin University of Technology, Bentley, Australia

Pharmaceutical care (PC) is a process through which a pharmacist works with other healthcare professionals and the patient to optimise pharmacotherapy. Early studies, carried out before PC was established, provided limited evidence of the benefits of pharmacist involvement in diabetes management. More recent research has examined the role of PC in a range of diabetic sub-groups. Although few of these studies were randomised, prospective and included clinically important end points such as HbA1C, some beneficial effects of PC were reported. In the most recent study, a 12-month randomised controlled trial of PC in community-based diabetic patients, regular face-to-face and telephone interviews with an experienced clinical pharmacist improved glycosylated haemoglobin while glycaemic control did not change in the controls. In addition, reductions in blood pressure, and in absolute vascular risk for patients with no history of coronary artery disease, were significantly greater in the PC group. Available evidence suggests that PC can prove a valuable component of community-based multi-disciplinary diabetes care.

Key Words: pharmaceutical care • diabetes • vascular risk factors.

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 6, 352-356 (2005)
DOI: 10.1177/14746514050050061001
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?